Prehospital point-of-care blood gas analysis associated with higher ambulatory treatment and admission rates in adult EMS patients.
This retrospective cohort study examined the impact of prehospital point-of-care blood gas analysis (BGA) conducted by emergency physicians in Jena, Germany. The population included 109 adult patients who received BGA and 98 who met inclusion criteria after exclusions, matched to 390 controls without BGA. The primary outcomes assessed were the proportion of patients treated on scene and the hospital admission rate among those transported to the hospital. Safety was evaluated over a 30-day follow-up period for ambulatory patients.
Results indicated that the ambulatory treatment rate was markedly higher in the BGA cohort compared with controls, with an odds ratio of 3.98 (95% CI 2.26 to 7.01). Specifically, 27.6% of BGA patients were treated on scene versus 8.7% of controls (p<0.001). Among patients transported to the hospital, the admission rate was 58% in the BGA cohort, compared to an overall regional emergency department conversion rate of approximately 30%.
Regarding safety, no ambulatory BGA patient required emergency department re-attendance or repeat EMS contact within 30 days. Serious adverse events, discontinuations, and specific tolerability data were not reported. The study acknowledges limitations inherent to retrospective analysis and its status as a pilot implementation. While integrating objective biochemical data may enhance treat-and-refer decision-making and support efficient use of emergency care capacity, the association between BGA and these outcomes does not establish causation.